Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole

Digestive Diseases and Sciences

Volumn 50, Issue 3, 2005, Pages 432-439

  Calleja, José L ^a,c   Suarez, Manuel ^b   De Tejada, Alberto Herreros ^a   Navarro, Angel ^d   Sanchiz, S ^e   Sempere, J ^e   Soto, J A ^e   Fernandez J J ^e   Gordillo, J O ^e   Porres, J C ^e   Allende, J J ^e   Zarate, J M ^e   Torrens, J ^e   Alvarez, M ^e   Fernandez M ^e   Gene, M ^e   Mancelle, R ^e   Mendez M A ^e   Villagrasa, M ^e   Lopez P ^e   De La Torre, F ^e   Garcia M ^e   Hergueta, P ^e   Payeras, G ^e   Barrio, J ^e   Vicente, D ^e   Vida, F ^e   Sebastian J J ^e   Madrona, C ^e   Gallego, F J ^e   Ramirez J ^e   Machancoses, A ^e   Martinez F J ^e   Vignote, M L ^e   Poyatos, A ^e   Jimenez C ^e   Gomez F ^e   Rubio, F ^e   Linares, A ^e   Cabrera, E ^e   Sanchez A ^e   more..

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

^c Scientific Research Department   (Spain)

^d Pantogerd Group   (Spain)

^e Hosp Universitario Puerta de Hierro ^*

Author keywords

Erosive esophagitis; Gastritis; GERD; Heartburn; Helicobacter pylori; Pantoprazole; Relapse

Indexed keywords

ANTIULCER AGENT; MAGALDRATE; OMEPRAZOLE; PANTOPRAZOLE; PROKINETIC AGENT; SUCRALFATE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG TOLERABILITY; ENDOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HEADACHE; HEALING; HEARTBURN; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; METEORISM; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFLUX ESOPHAGITIS; RELAPSE;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; BENZIMIDAZOLES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ESOPHAGITIS, PEPTIC; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HEARTBURN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SULFOXIDES; TIME FACTORS; TREATMENT OUTCOME;

EID: 20244372867     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2453-8     Document Type: Article

References (46)

1. Hackelsberger A, Schultze V, Gunther T: The prevalence of Helicobacter pylori gastritis in patients with reflux esophagitis: a case-control study. Eur J Gastroenterol Hepatol 10:465-468, 1998
2. Wu JC, Sung JJ, Ng EK: Prevalence and distribution of Helicobacter pylori in gastresophageal reflux disease: a study from the East. Am J Gastroenterol 94:1790-1794, 1999
3. Raghunath A, Hungin AP, Wooff D, Childs S: Prevalence of Helicobacter pylori in patients with gastro-esophageal reflux disease: systematic review. BMJ 5:326-337, 2003
4. Sharma P, Vakil N: Helicobacter pylori and reflux disease. Aliment Pharmacol Ther 17:297-305, 2003
5. Dixon MF: Patterns of inflammation linked to ulcer disease. Baillieres Best Pract Res Clin Gastroenterol 14:27-40, 2000
6. El-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE: Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 109:681-691, 1995
7. Moss SF, Calam J: Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut 34:888-892, 1993
8. El-Omar EM, Oien K, El-Nujumi A, et al.: Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 113:15-24, 1997
9. Koike T, Ohara S, Sekine H, et al.: Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am J Gastroenterol 94:3468-3472, 1999
10. Gutierrez O, Melo M, Segura AM, Angel A, Genta RM, Graham DY: Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol 32:664-668, 1997
11. Haruma K, Mihara M, Okamoto E, et al.: Erradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus-evaluation of 24 hour pH monitoring Gut 45:181-185, 1998
12. El-Serag HB, Sonnenberg A, Jamal MM, Inadomi JM, Crooks LA, Feddersen RM: Corpus gastritis is protective against reflux esophagitis. Gut 45:181-185, 1999
13. Koike T, Ohara S, Sekine H, et al.: Helicobacter pylori infection prevents erosive reflux esophagitis by decreasing gastric acid secretion. Gut 49:330-334, 2001
14. Gillen D, Wirz AA, Neithercut WD, Ardill JE, McColl KE: Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gut 44:468-475, 1999
15. Moayyedi P, Wason C, Peacock R, et al.: Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression. Helicobacter 5:206-2014, 2000
16. Wu JC, Chan FK, Ching JY, et al.: Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial. Gut 53:174-179, 2004
17. Rokkas T, Ladas SD, Triantafyllou K, et al.: The association between CagA status and the development of esophagitis after the eradication of Helicobacter pylori. Am J Med 110:703-707, 2001
18. Bercik P, Verdu E, Armstrong D, et al.: The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter infection. Am J Gastroenterol 95:947-955, 2000
19. Wu JC, Chan FK, Wong SK, Lee YT, Leung WK, Sung JJ: Effect of Helicobacter pylori eradication on esophageal acid exposure inpatients with reflux esophagitis. Aliment Pharmacol Ther 16:545-552, 2002
20. Manifold DK, Anggiansah A, Rowe I, Sanderson JD, Chinyama CN, Owen WJ: Gastro-esophageal reflux and duodenogastric reflux before and after eradication in Helicobacter pylori gastritis. Eur J Gastroenterol Hepatol 13:535-539, 2001
21. Tefera S, Hatlebakk JG, Berstad A: The effect of Helicobacter pylori eradication on gastro-esophageal reflux. Aliment Pharmacol Ther 13:915-920, 1999
22. Schwizer W, Thumshirn M, Dent J, et al.: Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet 357:1738-1742, 2001. Erratum: Lancet 358:1734, 2000
23. Moayyedi P, Bardhan C, Young L, Dixon MF, Brown L, Axon AT: Helicobacter pylori eradication does not exacerbate reflux symptoms in gastresophageal reflux disease. Gastroenterology 121:1120-1126, 2001
24. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G: Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112:1442-1447, 1997
25. Hamada H, Haruma K, Mihara M, et al.: High incidence of reflux esophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther 14:729-735, 2000
26. Fallone CA, Barkun AN, Friedman G, et al.: Is Helicobacter pylori eradication associated with gastresophageal reflux disease? Am J Gastroenterol 95:914-920, 2000
27. Miwa H, Sugiyama Y, Ohkusa T, et al.: Improvement of reflux symptoms 3 years after cure of Helicobacter pylori infection: a case-controlled study in the Japanese population. Helicobacter 7:219-224, 2002
28. Malfertheiner P, Dent J, Zeijlon L, et al.: Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease - Results from a randomized trial programme. Aliment Pharmacol Ther 16:1431-1442, 2002
29. Labenz J, Tillenburg B, Peitz U, et al.: Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 110:725-732, 1996
30. Loffeld RJ, van der Hulst RW: Helicobacter pylori and gastroesophageal reflux disease: association and clinical implications. To treat or not to treat with anti-H. pylori therapy? Scand J Gastroenterol Suppl 236:15-18, 2002
31. Holtmann G, Cain C, Malfertheiner P: Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology 117:11-16, 1999
32. Meneghelli UG, Boaventura S, Moraes-Filho JP, et al.: Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate. Dis Esophagus 15:50-56, 2002
33. Vakil N, Kahrilas P, Magner D, et al.: Does baseline H. pylori status impact erosive esophagitis healing rates? Am J Gastroenterol 95:2438, 2000
34. Vakil N, Zuckerman S, Levine J: H. pylori infection and the severity of esophagitis and healing with lansoprazole and esomeprazole. Gastroenterology 122:A-199, 2002
35. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Eskes SA, Meuwissen SG: Helicobacter pylori and the efficacy of omeprazole therapy for gastresophageal reflux disease. Am J Gastroenterol 94:884-887, 1999
36. Ollyo JB, Fontolliet Ch, Brossard E, et al.: La nouvelle classification de Savary des oesophagites de reflux. Acta Endosc 22:307-320, 1992
37. Armstrong D, Monnier P, Nicolet M, et al.: Endoscopic assessment of esophagitis. Gullet 1:63-67, 1991
38. Ollyo JB, Lang F, Fontolliet C, Monnier O: Savary-Miller's new endoscopic grading of reflux-oesophagitis: a simple, reproductible, logical, complete and useful classification. Gastroenterology 98:A100, 1990
39. Svedlund J, Sjodin I, Dotevall G: GSRS - A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33:129-134, 1988
40. Revicki DA, Wood M, Wiklund I, Crawley J: Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 7:75-83, 1998
41. Martin de Argila C, Boixeda D, Cantón R, et al.: Helicobacter pylori infection in a healthy population in Spain. Eur J Gastroenterol Hepatol 8:1165-1168, 1996
42. Metz DC, Bochenek WJ: Pantoprazole US GERD Study Group. Pantoprazole maintenance therapy prevents relapse of erosive esophagitis. Aliment Pharmacol Ther 17:155-164, 2003
43. Carlsson R, Bate C, Dent J: Does H. pylori infection influence in the response to treatment with acid inhibition in patients with GERD? Scand J Gastroenterol 32 (Suppl 224):F70, 1997
44. Vakil N: Gastresophageal reflux disease and Helicobacter pylori infection. Rev Gastroenterol Disord 3:1-7, 2003
45. Malfertheiner P, Megraud F, O'Morain C, et al.: Current concepts in the management of Helicobacter pylori infection - The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 16:167-180, 2002
46. Armstrong D, Bennett JR, Blum AL, et al.: Gastroenterology 111:85-92, 1996